Where Travere Therapeutics Stands With Analysts
Where Travere Therapeutics Stands With Analysts
分析師對Travere Therapeutics的看法
The standing of Travere Therapeutics among financial experts becomes clear with...Travere Therapeutics (NASDAQ:TVTX) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Travere Therapeutics（納斯達克股票代碼：TVTX）在上個季度接受了14位分析師的分析，揭示了從看漲到看跌的一系列觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $19.79, with a high estimate of $25.00 and a low estimate of $12.00. This current average reflects an increase of 11.37% from the previous average price target of $17.77.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標價爲19.79美元，最高估計爲25.00美元，低估值爲12.00美元。目前的平均價格比之前的平均目標價17.77美元增長了11.37％。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：仔細觀察
The standing of Travere Therapeutics among financial experts becomes clear with...
通過對分析師近期行爲的...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間